top of page
it's where dermatology lives




1/2


VIDEO: Study shows ivarmacitinib safe, efficacious in treating moderate-to-severe AD
Ivarmacitinib has been shown to be effective and safe in treating adolescent and adult patients with AD.
Jeremy Visser
Jul 2, 20251 min read


Dog ownership may mitigate one genetic eczema risk factor
Image by Standl M. et al. CC:BY Findings from a new study suggest early-life exposure to domestic dogs may modify the effect of one...
John Evans
Jun 6, 20252 min read


VIDEO: Pediatric and adolescent patients with moderate-to-severe AD experience significant disease burden
Patients with moderate-to-severe AD experience significant disease burden with physical, emotional, and social impact.
Jeremy Visser
May 21, 20251 min read


AD biologic non-responders benefit from extended Tx
Photo by Dwxn via Wikimedia Commons New research reveals that patients with moderate-to-severe atopic dermatitis (AD) who did not...
John Evans
May 16, 20251 min read


VIDEO: Study shows early-onset pediatric AD linked to higher risk of uveitis
Children with early-onset pediatric AD have an increased incidence for uveitis.
Jeremy Visser
Apr 30, 20251 min read


May 10, 2025: Save the date for the 2025 Skin Spectrum Summit on Atopic Dermatitis
Mark your calendar for the 2025 edition of the Summit on Atopic Dermatitis virtual conference on May 10, from 10:00 a.m. to 1:00 p.m....
Allan Ryan
Apr 7, 20251 min read


VIDEO: GP, Dermatologist discuss therapeutic options for AD
Dr. Christine Neagoe and Dr. Mohannad Abu-Hilal recently discussed the management of AD through topical and systemic treatments.
Jeremy Visser
Feb 5, 20251 min read


Chronic hand eczema affects 4.7% of adults in Europe and Canada, study finds
Photo by: JIP via Wikimedia Commons A new study in the British Journal of Dermatology has determined that chronic hand eczema (CHE)...
Allan Ryan
Jan 20, 20252 min read
Featured Posts


bottom of page
